IP Library Granted Patent US 7,351,213
Granted Patent B2
US 7,351,213 · App. 11/105,209 · Granted Apr 1, 2008

Integrated spot monitoring device with fluid sensor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,351,213
App. No.
11/105,209
Granted
Apr 1, 2008
Kind
B2
Abstract

A bodily fluid sampling device is operable to breach the skin surface and allow bodily fluid to emerge from the breach location. The bodily fluid sampling device further evaluates the amount of bodily fluid emerged from breach location and determines whether the amount is sufficient or insufficient for a particular purpose, such as sampling and testing. The determination is accomplished automatically without moving the device. The user may also intervene to perform a variety of tasks following the determination of the amount of bodily fluid.

Claims (24)

1. A method, comprising:

placing a sampling device against a tissue;

creating an incision in the tissue with the sampling device;

detecting with the sampling device that body fluid bled from the incision on the tissue is insufficient for analysis; and

expressing the body fluid from the incision automatically with the sampling device in response to said detecting while the sampling device remains against the tissue;

wherein the sampling device includes a housing with a cavity and a fluid detector configured to generate ultrasound in the cavity;

wherein said detecting includes monitoring resonance of the ultrasound in the cavity of the housing;

sensing an ultrasonic resonance that indicates the sampling device is placed against the tissue; and

said creating the incision including firing a lancet into the tissue in response to said sensing the ultrasonic resonance that indicates the sampling device is placed against the tissue.

2. The method of claim 1 , wherein said detecting includes monitoring rate of bleeding of the body fluid from the incision.

3. The method of claim 1 , wherein said detecting includes monitoring amount of body fluid on the tissue.

4. The method of claim 1 , further comprising:

determining with the sampling device that the body fluid on the tissue is sufficient for analysis after said expressing; and

analyzing the body fluid with the sampling device after said determining.

5. The method of claim 1 , wherein said expressing includes electrically stimulating the tissue with electrodes of the sampling device.

6. The method of claim 1 , further comprising:

wherein the sampling device includes an output device; and

activating the output device to indicate insufficiency of the body fluid upon said detecting.

7. The method of claim 1 , further comprising:

wherein said detecting includes determining the location of the body fluid bled from the incision; and

extending a test strip to the location of the body fluid by adjusting how far the test strip extends based on said determining the location of the body fluid.

8. The method of claim 1 , further comprising:

wherein said detecting includes determining the location of the surface of the tissue; and

extending a test strip to collect the body fluid by adjusting how far the test strip extends based on said determining the location of the surface of the tissue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 036008/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2005
From: WONG, DANIEL; WIEGEL, CHRISTOPHER
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 016473/0028 →